List of Esperion Therapeutics patents

Patents where

Current Assignee

Name

Esperion Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10118881 Hydroxyl compounds and compositions for cholesterol management and related uses	Patent 10118881 was granted and assigned to Esperion Therapeutics on November, 2018 by the United States Patent and Trademark Office.	Esperion Therapeutics	Esperion Therapeutics	United States Patent and Trademark Office	10118881	November 6, 2018
‌ US Patent 7335799 Hydroxyl compounds and compositions for cholesterol management and related uses	Patent 7335799 was granted and assigned to Esperion Therapeutics on February, 2008 by the United States Patent and Trademark Office.		Esperion Therapeutics	United States Patent and Trademark Office	7335799	February 26, 2008
‌ US Patent 9624152 Hydroxyl compounds and compositions for cholesterol management and related uses	Patent 9624152 was granted and assigned to Esperion Therapeutics on April, 2017 by the United States Patent and Trademark Office.		Esperion Therapeutics	United States Patent and Trademark Office	9624152	April 18, 2017
‌ US Patent 9000041 Hydroxyl compounds and compositions for cholesterol management and related uses	Patent 9000041 was granted and assigned to Esperion Therapeutics on April, 2015 by the United States Patent and Trademark Office.		Esperion Therapeutics	United States Patent and Trademark Office	9000041	April 7, 2015
‌ US Patent 10047028 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses	Patent 10047028 was granted and assigned to Esperion Therapeutics on August, 2018 by the United States Patent and Trademark Office.		Esperion Therapeutics	United States Patent and Trademark Office	10047028	August 14, 2018
‌ US Patent 9006290 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses	Patent 9006290 was granted and assigned to Esperion Therapeutics on April, 2015 by the United States Patent and Trademark Office.		Esperion Therapeutics	United States Patent and Trademark Office	9006290	April 14, 2015
‌ US Patent 9452964 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses	Patent 9452964 was granted and assigned to Esperion Therapeutics on September, 2016 by the United States Patent and Trademark Office.		Esperion Therapeutics	United States Patent and Trademark Office	9452964	September 27, 2016
‌ US Patent 7335689 Dihydroxyl compounds and compositions for cholesterol management and related uses	Patent 7335689 was granted and assigned to Esperion Therapeutics on February, 2008 by the United States Patent and Trademark Office.		Esperion Therapeutics	United States Patent and Trademark Office	7335689	February 26, 2008
‌ US Patent 6909014 Intermediates for the synthesis of ether compounds	Patent 6909014 was granted and assigned to Esperion Therapeutics on June, 2005 by the United States Patent and Trademark Office.		Esperion Therapeutics	United States Patent and Trademark Office	6909014	June 21, 2005
‌ US Patent 6953840 Methods of using non-human animal Apolipoprotein A-I protein	Patent 6953840 was granted and assigned to Esperion Therapeutics on October, 2005 by the United States Patent and Trademark Office.		Esperion Therapeutics	United States Patent and Trademark Office	6953840	October 11, 2005
‌ US Patent 11407705 Methods of making bempedoic acid and compositions of the same	Patent 11407705 was granted and assigned to Esperion Therapeutics on August, 2022 by the United States Patent and Trademark Office.	Esperion Therapeutics	Esperion Therapeutics	United States Patent and Trademark Office	11407705	August 9, 2022
‌ US Patent 10912751 Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease	Patent 10912751 was granted and assigned to Esperion Therapeutics on February, 2021 by the United States Patent and Trademark Office.	Esperion Therapeutics	Esperion Therapeutics	United States Patent and Trademark Office	10912751	February 9, 2021
‌ US Patent 9610324 Apolipoprotein mixtures	Patent 9610324 was granted and assigned to Esperion Therapeutics on April, 2017 by the United States Patent and Trademark Office.		Esperion Therapeutics	United States Patent and Trademark Office	9610324	April 4, 2017
‌ US Patent 10941095 Hydroxyl compounds and compositions for cholesterol management and related uses	Patent 10941095 was granted and assigned to Esperion Therapeutics on March, 2021 by the United States Patent and Trademark Office.	Esperion Therapeutics	Esperion Therapeutics	United States Patent and Trademark Office	10941095	March 9, 2021
‌ US Patent 8975300 Ketone compounds and compositions for cholesterol management and related uses	Patent 8975300 was granted and assigned to Esperion Therapeutics on March, 2015 by the United States Patent and Trademark Office.		Esperion Therapeutics	United States Patent and Trademark Office	8975300	March 10, 2015
‌ US Patent 6974702 Fourier transform mass spectrometry of complex biological samples	Patent 6974702 was granted and assigned to Esperion Therapeutics on December, 2005 by the United States Patent and Trademark Office.		Esperion Therapeutics	United States Patent and Trademark Office	6974702	December 13, 2005
‌ US Patent 11987548 Methods of making bempedoic acid and compositions of the same	Patent 11987548 was granted and assigned to Esperion Therapeutics on May, 2024 by the United States Patent and Trademark Office.	Esperion Therapeutics	Esperion Therapeutics	United States Patent and Trademark Office	11987548	May 21, 2024
‌ US Patent 11926584 Methods of making bempedoic acid and compositions of the same	Patent 11926584 was granted and assigned to Esperion Therapeutics on March, 2024 by the United States Patent and Trademark Office.	Esperion Therapeutics	Esperion Therapeutics	United States Patent and Trademark Office	11926584	March 12, 2024
‌ US Patent 11744816 Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease	Patent 11744816 was granted and assigned to Esperion Therapeutics on September, 2023 by the United States Patent and Trademark Office.	Esperion Therapeutics	Esperion Therapeutics	United States Patent and Trademark Office	11744816	September 5, 2023
‌ US Patent 11760714 Methods of making bempedoic acid and compositions of the same	Patent 11760714 was granted and assigned to Esperion Therapeutics on September, 2023 by the United States Patent and Trademark Office.	Esperion Therapeutics	Esperion Therapeutics	United States Patent and Trademark Office	11760714	September 19, 2023

20 results

0 selected

20 results

0 selected